Boosting the dose: new approaches needed

French researchers have investigated whether a selective radiotherapy dose increase to tumour areas with significant uptake of 18F-FMISO – a PET radio-tracer used to diagnose hypoxia – could improve outcomes in patients with non-small cell lung cancer.
Medical Physics Web